STAT - Reporting from the frontiers of health and medicine

Health

Exclusive

Biotech

Health The PPE crisis didn’t go away: Across the U.S., grassroots supply networks are trying to fill the void
Politics Burr, in line to lead Senate Republicans’ health strategy, has a long history of antagonizing the FDA
Pharma STAT+ Conversations: A conversation on drug pricing, policy, and access
Biotech How nanotechnology helps mRNA Covid-19 vaccines work
First Opinion The U.S. must support access to care and incentives for the innovation that transforms it

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

HHS spikes a drug approval program that inadvertently led to price hikes and shortages
Startup Spotlight: Bullish on its asthma treatment, Kinaset forges ahead in unusual times
Medicines Patent Pool expands deal for access to key HIV drug to several upper middle-income countries

Health

Don't Miss

By STAT staff

Health Tech

By Juliet Isselbacher

Special Report

Health

By Gabrielle Glaser

Health

By Amy Sokolow

Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Biotech How nanotechnology helps mRNA Covid-19 vaccines work
Health ‘A huge experiment’: How the world made so much progress on a Covid-19 vaccine so fast
Biotech Moderna to submit Covid-19 vaccine to FDA as full results show 94% efficacy
Health Covid-19 vaccine from Pfizer and BioNTech is strongly effective, early data from large trial indicate
Exclusive White House to host Covid-19 vaccine summit, as Trump seeks to burnish record
Exclusive Divisions emerge among U.S. officials over when first Covid-19 vaccine doses will be available — and for whom
Health He experienced a severe reaction to Moderna’s Covid-19 vaccine candidate. He’s still a believer